Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.

Wi CI, Kim WR, Gross JB, Stadheim LM, Poterucha JJ.

Gut Liver. 2016 Jul 16;10(4):611-6. doi: 10.5009/gnl14256.

2.

Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.

Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS; Hepatitis B Research Network; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92. doi: 10.1016/j.cgh.2014.06.028. Epub 2014 Jul 8.

3.

Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.

Roberts KE, Kawut SM, Krowka MJ, Brown RS Jr, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB; Pulmonary Vascular Complications of Liver Disease Study Group.

Gastroenterology. 2010 Jul;139(1):130-9.e24. doi: 10.1053/j.gastro.2010.03.044. Epub 2010 Mar 24.

4.

Plasma levels of S100A4 in portopulmonary hypertension.

Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS Jr, Fallon MB, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Biomarkers. 2009 May;14(3):156-60. doi: 10.1080/13547500902773896.

5.

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Am J Respir Crit Care Med. 2009 May 1;179(9):835-42. doi: 10.1164/rccm.200809-1472OC. Epub 2009 Feb 12.

6.

Serotonin transporter polymorphisms in patients with portopulmonary hypertension.

Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS Jr, Taichman DB, Trotter J, Zacks S, Horn EM, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Chest. 2009 Jun;135(6):1470-5. doi: 10.1378/chest.08-1909. Epub 2009 Jan 13.

7.

Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.

Rybak D, Fallon MB, Krowka MJ, Brown RS Jr, Reinen J, Stadheim L, Faulk D, Nielsen C, Al-Naamani N, Roberts K, Zacks S, Perry T, Trotter J, Kawut SM; Pulmonary Vascular Complications of Liver Disease Study Group.

Liver Transpl. 2008 Sep;14(9):1357-65. doi: 10.1002/lt.21545.

8.

Clinical risk factors for portopulmonary hypertension.

Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB; Pulmonary Vascular Complications of Liver Disease Study Group.

Hepatology. 2008 Jul;48(1):196-203. doi: 10.1002/hep.22275.

9.

A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices.

Perri RE, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, Shah ND, Kamath PS.

Hepatology. 2008 May;47(5):1587-94. doi: 10.1002/hep.22219.

PMID:
18393388
10.

Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinoma.

Baskin-Bey ES, Devarbhavi HC, Nagorney DM, Farnell MB, Donohue JH, Sanderson SO, Stadheim LM, Gores GJ.

HPB (Oxford). 2005;7(4):283-8. doi: 10.1080/13651820500292954.

11.

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.

Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267.

12.

Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Dunn W, Angulo P, Sanderson S, Jamil LH, Stadheim L, Rosen C, Malinchoc M, Kamath PS, Shah VH.

Gastroenterology. 2006 Oct;131(4):1057-63. Epub 2006 Aug 10.

13.

Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease.

Reddy A, Dash C, Leerapun A, Mettler TA, Stadheim LM, Lazaridis KN, Roberts RO, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):118-23. Epub 2006 Sep 26.

PMID:
17008133
14.

MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE.

J Cancer Res Clin Oncol. 2006 Mar;132(3):159-62. Epub 2005 Nov 15.

PMID:
16292541
15.

Octreotide therapy for advanced hepatocellular carcinoma.

Slijkhuis WA, Stadheim L, Hassoun ZM, Nzeako UC, Kremers WK, Talwalkar JA, Gores GJ.

J Clin Gastroenterol. 2005 Apr;39(4):333-8.

PMID:
15758629
16.

Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.

Harewood GC, Baron TH, Rumalla A, Wang KK, Gores GJ, Stadheim LM, de Groen PC.

J Gastroenterol Hepatol. 2005 Mar;20(3):415-20.

PMID:
15740486
17.

A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.

Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR.

Am J Gastroenterol. 2004 Sep;99(9):1675-81.

PMID:
15330900
18.

Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation.

Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR.

Am J Gastroenterol. 2004 Aug;99(8):1464-9.

PMID:
15307861
19.

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis.

Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V.

Am J Gastroenterol. 2004 Feb;99(2):255-60.

PMID:
15046213
20.

A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures.

Baron TH, Harewood GC, Rumalla A, Pochron NL, Stadheim LM, Gores GJ, Therneau TM, De Groen PC, Sebo TJ, Salomao DR, Kipp BR.

Clin Gastroenterol Hepatol. 2004 Mar;2(3):214-9.

PMID:
15017605
Items per page

Supplemental Content

Loading ...
Write to the Help Desk